Transcriptional_JJ
and_CC
posttranscriptional_JJ
regulation_NN
of_IN
erythroid_JJ
gene_NN
expression_NN
in_IN
anthracycline-induced_JJ
differentiation_NN
of_IN
human_JJ
erythroleukemic_JJ
cells_NNS
._.

Aclacinomycin_NN
-LRB-_-LRB-
ACLA_NN
-RRB-_-RRB-
and_CC
doxorubicin_NN
-LRB-_-LRB-
DOX_NN
-RRB-_-RRB-
were_VBD
used_VBN
at_IN
subtoxic_JJ
concentrations_NNS
to_TO
induce_VB
erythroid_JJ
differentiation_NN
in_IN
the_DT
human_JJ
leukemic_JJ
cell_NN
line_NN
K562_NN
._.

Cell_NN
hemoglobinization_NN
was_VBD
accompanied_VBN
by_IN
the_DT
increased_VBN
expression_NN
of_IN
genes_NNS
encoding_VBG
gamma-globin_NN
and_CC
porphobilinogen_NN
deaminase_NN
-LRB-_-LRB-
PBGD_NN
-RRB-_-RRB-
,_,
an_DT
enzyme_NN
of_IN
heme_NN
synthesis_NN
._.

By_IN
using_VBG
run-on_JJ
assays_NNS
,_,
ACLA_NN
was_VBD
shown_VBN
to_TO
induce_VB
an_DT
enhancement_NN
of_IN
the_DT
transcription_NN
of_IN
erythroid_JJ
genes_NNS
,_,
including_VBG
gamma-globin_NN
,_,
PBGD_NN
,_,
erythropoietin_NN
receptor_NN
,_,
and_CC
GATA-1_NN
transcription_NN
factor_NN
._.

In_IN
contrast_NN
,_,
in_IN
DOX-treated_JJ
cells_NNS
,_,
the_DT
transcription_NN
rate_NN
of_IN
these_DT
genes_NNS
was_VBD
unchanged_JJ
in_IN
comparison_NN
with_IN
control_NN
cells_NNS
._.

In_IN
addition_NN
,_,
inhibition_NN
of_IN
mRNA_NN
synthesis_NN
with_IN
actinomycin_NN
D_NN
indicated_VBD
that_IN
DOX_NN
induced_VBD
an_DT
increased_VBN
stability_NN
of_IN
PBGD_NN
and_CC
GATA-1_NN
mRNAs_NNS
,_,
whereas_IN
ACLA_NN
did_VBD
not_RB
affect_VB
the_DT
half-lives_NNS
of_IN
these_DT
mRNAs_NNS
._.

Because_IN
the_DT
increase_NN
in_IN
erythroid_JJ
mRNA_NN
steady-state_JJ
level_NN
in_IN
anthracycline-treated_JJ
cells_NNS
was_VBD
inhibited_VBN
by_IN
cycloheximide_NN
,_,
this_DT
suggests_VBZ
that_IN
transcriptional_JJ
activation_NN
in_IN
ACLA-treated_JJ
cells_NNS
and_CC
mRNA_NN
stabilization_NN
in_IN
DOX-treated_JJ
cells_NNS
were_VBD
dependent_JJ
on_IN
de_FW
novo_FW
protein_NN
synthesis_NN
._.

Finally_RB
,_,
GATA-1_NN
protein_NN
level_NN
was_VBD
shown_VBN
to_TO
be_VB
increased_VBN
in_IN
ACLA-treated_JJ
but_CC
not_RB
in_IN
DOX-treated_JJ
cells_NNS
._.

These_DT
two_CD
anthracyclines_NNS
,_,
although_IN
closely_RB
related_JJ
in_IN
their_PRP$
structures_NNS
,_,
appeared_VBD
to_TO
act_VB
as_IN
differentiation_NN
inducers_NNS
by_IN
distinct_JJ
mechanisms_NNS
._.

Indeed_RB
,_,
erythroid_JJ
gene_NN
expression_NN
was_VBD
demonstrated_VBN
to_TO
be_VB
regulated_VBN
transcriptionally_RB
by_IN
ACLA_NN
and_CC
mainly_RB
posttranscriptionally_RB
by_IN
DOX_NN
._.

